Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?

被引:4
|
作者
Augustin, Herbert [1 ]
Mayerhofer, Katrin [1 ]
Seles, Maximilian [1 ]
Pummer, Karl [1 ]
机构
[1] Med Univ Graz, Dept Urol, AT-8036 Graz, Austria
关键词
Active surveillance; Prostate cancer; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; FOLLOW-UP; MEN; BIOPSY; TIME; CANDIDATES; ANTIGEN; OVERDIAGNOSIS; ASSOCIATION;
D O I
10.1159/000371895
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Active surveillance (AS) represents an expectant treatment strategy for clinically localized prostate cancer (PCa) with low-risk features. Objective: The actual management as well as the pros and cons of AS were evaluated. Methods: A systematic review of the recent literature was performed using the Medline databases. Conclusions: Since a substantial number of men die with rather than from PCa, there is a considerable role for AS in carefully selected men. AS may also represent a strategy to reduce the burden of overtreatment rooted in intensified PSA testing. Facing the imprecision of risk stratification based on transrectal ultra-sound- guided biopsy, accurate clinical staging represents a major medical challenge. Counseling and care require empathy as well as a profound understanding of the biology and the natural history of PCa. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:125 / 131
页数:7
相关论文
共 50 条
  • [1] Active surveillance for low-risk prostate cancer
    Klotz, Laurence
    [J]. CURRENT OPINION IN UROLOGY, 2017, 27 (03) : 225 - 230
  • [2] Active surveillance for low-risk prostate cancer
    Herlemann, Annika
    Stief, Christian G.
    [J]. UROLOGE, 2016, 55 (02): : 269 - 278
  • [3] Active Surveillance for Low-risk Prostate Cancer
    Mazzucchelli, Roberta
    Nesseris, Ioannis
    Cheng, Liang
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    Scarpelli, Marina
    [J]. ANTICANCER RESEARCH, 2010, 30 (09) : 3683 - 3692
  • [4] Active Surveillance for Low-Risk Prostate Cancer
    Laurence Klotz
    [J]. Current Urology Reports, 2015, 16
  • [5] Active surveillance for low-risk prostate cancer
    Hadjipavlou, Marios
    Promponas, John
    Madaan, Sanjeev
    [J]. JOURNAL OF CLINICAL UROLOGY, 2015, 8 (06) : 420 - 428
  • [6] Active surveillance for low-risk prostate cancer
    Bangma, Chris H.
    Bul, Meelan
    van der Kwast, Theo H.
    Pickles, Tom
    Korfage, Ida J.
    Hoeks, Caroline M.
    Steyerberg, Ewout W.
    Jenster, Guido
    Kattan, Michael W.
    Bellardita, Lara
    Carroll, Peter R.
    Denis, Louis J.
    Parker, Chris
    Roobol, Monique J.
    Emberton, Mark
    Klotz, Laurence H.
    Rannikko, Antti
    Kakehi, Yoshiyuki
    Lane, Janet A.
    Schroder, Fritz H.
    Semjonow, Axel
    Trock, Bruce J.
    Valdagni, Riccardo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 295 - 302
  • [7] Active Surveillance for Low-Risk Prostate Cancer
    Klotz, Laurence
    [J]. CURRENT UROLOGY REPORTS, 2015, 16 (04) : 1 - 10
  • [8] Active surveillance preferred for low-risk prostate cancer
    Bagcchi, Sanjeet
    [J]. LANCET ONCOLOGY, 2015, 16 (08): : E384 - E384
  • [9] Active surveillance for low-risk prostate cancer: an update
    Nathan Lawrentschuk
    Laurence Klotz
    [J]. Nature Reviews Urology, 2011, 8 : 312 - 320
  • [10] Active Surveillance for Low-Risk Localized Prostate Cancer
    Large, Michael C.
    Eggener, Scott E.
    [J]. ONCOLOGY-NEW YORK, 2009, 23 (11): : 974 - 979